BioWorld

Sep. 7, 2004

World's Largest Nation Drawing Attention From Biotech, Pharma

States Angling To Control Reimportation, Stem Cells

Holiday Notice

BioWorld Today's offices are closed Monday, Sept. 6, in observance of Labor Day. No issue will be published. Read More

Other News To Note

MediciNova $44M Financing To Advance Products To Phase II

As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today) Read More

NeoPharm's Kapoor Makes Bid To Change Board, Reduce Costs

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...